AR and prostate cancer: Despite these findings, miR-16 is still commonly used as an endogenous qPCR normalizer [82], even though PCa cell studies show marked down-regulation of miR-16-5p and functional targeting of AR and EGFR, both closely linked to prostate cancer biology [83].